Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls

• Published in: Molecular genetics and metabolism Vol. 121; no. 1; pp. 51 - 56
• Main Authors: Nordang, Gry B.N., Busk, Øyvind L., Tveten, Kristian, Hanevik, Hans Ivar, Fell, Anne Kristin M., Hjelmesæth, Jøran, Holla, Øystein L., Hertel, Jens K.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-05-2017
• Subjects: Adolescent; Adult; Age Distribution; BMI; Case-Control Studies; Child; Female; Genetic Predisposition to Disease; Genetic Variation; High-Throughput Nucleotide Sequencing - methods; Humans; Leptin - genetics; Male; Middle Aged; Morbid obesity; Mutation; Mutation Rate; Next-generation sequencing; Norway; Obesity, Morbid - genetics; Pro-Opiomelanocortin - genetics; Proprotein Convertase 1 - genetics; Rare sequence variant; Receptor, Melanocortin, Type 4 - genetics; Receptors, Leptin - genetics; Sequence Analysis, DNA - methods; Young Adult; Norway; Rare sequence variant; Next-generation sequencing; Morbid obesity; Mutation; BMI
• ISSN: 1096-7192; 1096-7206
• DOI: 10.1016/j.ymgme.2017.03.007

Rare sequence variants in at least five genes are known to cause monogenic obesity. In this study we aimed to investigate the prevalence of, and characterize, rare coding and splice site variants in LEP, LEPR, MC4R, PCSK1 and POMC in patients with morbid obesity and normal weight controls.
Targeted next-generation sequencing of all exons in LEP, LEPR, MC4R, PCSK1 and POMC was performed in 485 patients with morbid obesity and 327 normal weight population-based controls from Norway.
In total 151 variants were detected. Twenty-eight (18.5%) of these were rare, coding or splice variants and five (3.3%) were novel. All individuals, except one control, were heterozygous for the 28 variants, and the distribution of the rare variants showed a significantly higher carrier frequency among cases than controls (9.9% vs. 4.9%, p=0.011). Four variants in MC4R were classified as pathogenic or likely pathogenic.
Four cases (0.8%) of monogenic obesity were detected, all due to MC4R variants previously linked to monogenic obesity. Significant differences in carrier frequencies among patients with morbid obesity and normal weight controls suggest an association between heterozygous rare coding variants in these five genes and morbid obesity. However, additional studies in larger cohorts and functional testing of the novel variants identified are required to confirm the findings.